Browse Category

Earnings Reports 12 January 2026 - 13 January 2026

UnitedHealth (UNH) stock falls on Senate Medicare report as earnings near

UnitedHealth (UNH) stock falls on Senate Medicare report as earnings near

Shares of UnitedHealth Group dropped Monday following a U.S. Senate committee report accusing the insurer of using aggressive risk-adjustment coding to increase Medicare Advantage payments. The stock closed down nearly 2% at $337.15, then edged up about 1% to $340.51 in after-hours trading. The report intensifies scrutiny of UnitedHealth’s Medicare billing practices, coming after the company disclosed last year it was cooperating with U.S. Justice Department inquiries.
JPMorgan stock slides after Trump credit-card rate cap call; earnings and CPI due Tuesday

JPMorgan stock slides after Trump credit-card rate cap call; earnings and CPI due Tuesday

Shares of JPMorgan Chase & Co slipped Monday following President Donald Trump’s call for a one-year 10% cap on credit-card interest rates starting Jan. 20, stirring fears over a crucial revenue stream for major banks. JPM fell 1.5% in after-hours, closing at $324.49 after hitting a low of $317.34 during the day. Bank of America dropped 1.6%, while Citigroup slid 3.7% in early trade. UBS analysts noted that such a cap would require “an Act of Congress” to become reality.
Microsoft stock slips after the bell as Goldman flags “compounding AI cycles” ahead of earnings

Microsoft stock slips after the bell as Goldman flags “compounding AI cycles” ahead of earnings

Microsoft Corp shares slipped about 0.4% after Monday’s close, landing at $477.22, with intraday moves ranging from $474.45 to $480.88. Goldman Sachs analyst Gabriela Borges resumed coverage, assigning a Buy rating and lifting her 12-month price target to $655 from $630. She noted Microsoft stands out among megacaps to capitalize on “compounding AI product cycles.” The company’s market cap sits near $3.85 trillion.
1 161 162 163 164 165 271
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

Xylem

NYSE: XYL 95 / 100
#2 BUY

AerCap

NYSE: AER 93 / 100
#3 BUY ON WEAKNESS

Visa

NYSE: V 90 / 100
#4 TACTICAL BUY

Chevron

NYSE: CVX 87 / 100
#5 ACCUMULATE

UPS

NYSE: UPS 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.